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ABSTRACT 
The emergence of the first commercialized DNA vaccine for fish had prompted for studies that are focused 
on the development of a more efficacious vaccine that can protect cultured fish against virus infection. This 
DNA vaccine designed to express viral glycoprotein (G) gene was proven to effectively give protection to 
several species of fish against rhabdoviruses (ex. viral hemorrhagic septicemia virus, VHSV). Thus, the 
addition of molecular adjuvant to the DNA vaccine has been considered to be one of the best methods in 
improving the vaccine’s capability since its presence triggers a more enhanced immune response. DDx41, 
a cytosolic sensor, has the ability to activate an antiviral cascade of events in response to stimulation of a 
DNA virus making it a good molecular adjuvant candidate. In the present study, we designed a DNA 
vaccine consisting of VHSV glycoprotein (VHSVg) and DDx41 which is regulated by EF-1α and CMV 
promoters, respectively. The aim is to develop a DNA vaccine that can elicit a stronger immune response 
that could protect the fish against VHSV infection. Four plasmid constructs were prepared for the 
experiment: pEF-A (empty vector), pEF-G (with VHSVg), pEF-D (with DDx41) and pEF-GD (both 
VHSVg and DDx41). Expression of individual genes was checked using Western Blot assay, VHSVg in 
pEF-G and DDx41 in pEF-D were detected using V5 antibody while DDx41 in pEF-GD was detected using 
myc antibody. Several immune response genes were also evaluated through qPCR to further elucidate the 
antiviral effect of the plasmid constructs. ∆∆Ct method was utilized to quantify the fold changes of the 
immune gene transcripts after immunization. qPCR results showed that there are significant increases in 
the transcript number of IRF-1, ISG-15, and IRF-3  (p< 0.05) as well as IFN-1 (p<0.1) in cells that were 
immunized with the vaccine-adjuvant construct, pEF-GD, compared to the control plasmid, pEF-A. The 
results implicated the strength of DDx41 in inducing IFN-mediated immune responses which demonstrates 
its ability as a molecular adjuvant. This is essential since majority of the DNA vaccines against fish 
rhabdovirus that we have now are purely based on viral glycoprotein and though it has been proven to be 
effective, the development of a more efficient DNA vaccine that can improve fish immunity against 
rhabdovirus infection is significantly beneficial to the aquaculture industry. 
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